AI Development Company

AI Systems

#1 in Top 100 AI Companies Clutch, 2025

Accelerate innovation in Pharma and Healthcare with AI ML development services from Blackthorn AI.

industries

With a proven track record across 100+ AI projects, our PhD-level team builds scalable, research-grade solutions for biotech innovation, healthcare analytics, fintech optimization, and energy intelligence.

All Industries
Case Studies

AI-Powered Solutions
 We Delivered

About Us

Blackthorn AI is a leading expert in AI software development, delivering innovative solutions tailored to meet diverse business needs.

Read more

0+

Projects 
delivered

0+

Peer-reviewed publication

0+

PhD-Level 
Experts

0+

Years of full-cycle development experience

Our team

Blackthorn AI’s team combines deep technical expertise with a thorough understanding of industry challenges, offering bespoke AI solutions that empower businesses to innovate and excel in a competitive market.

Alex Gurbych, PhD

Chief Executive Officer (CEO)

Alex Gurbých, PhD in AI, has over 15 years of experience turning advanced research into practical systems for global companies including Google, Shell, and Bayer. He has published in Nature, presented at NeurIPS, and received multiple awards for AI research.

Alongside industry work, Alex spent 8+ years teaching AI and mentoring engineers, building a rare mix of scientific depth and hands-on execution that shaped the vision for Blackthorn AI.

Alex Gurbych, PhD

Chief Executive Officer (CEO)

Natalya Shakhovska, DrSci, Prof.

Chief Scientific Officer

Natalya Shakhovska is one of Ukraine’s leading scientists in artificial intelligence and data systems. With more than 350 scientific publications, 9 monographs, and 6 textbooks, she has shaped the direction of research in NLP, big data, and distributed systems for decades.

At Blackthorn AI, she brings deep scientific rigor to product development, ensuring that every solution stands on a solid foundation of validated methods and scalable data-driven architectures. Her work as CSO connects frontier research with practical business impact, making complex AI systems reliable for high-stakes industries.

Natalya Shakhovska, DrSci, Prof.

Chief Scientific Officer

Dmytro Krasnienkov, PhD

Principal Scientist, Bioinformatics

Dmytro Krasnienkov is a geneticist and bioinformatics researcher with over a decade of experience in epigenetics and aging science. As Head of the Laboratory of Epigenetics at the D.F. Chebotarev Institute of Gerontology, he has led studies on genetic regulation and its impact on longevity. At Blackthorn AI, Dmytro applies his expertise in genomics and computational biology to design AI-driven pipelines for multi-omics data analysis and biomarker discovery. His background bridges academic research and applied biotech, ensuring that scientific rigor translates into scalable AI solutions for healthcare and life sciences.

Dmytro Krasnienkov, PhD

Principal Scientist, Bioinformatics

Werner Baumgartner

Director DACH & MENA

With over two decades of international experience, Werner leads Blackthorn AI’s business development across the DACH and MENA regions. His background spans market access, strategic partnerships, and growth acceleration for tech and innovation-driven companies. Before joining Blackthorn AI, Werner built a strong track record guiding organizations through complex market landscapes in Europe and the Middle East – helping them translate strategic vision into measurable results.
At Blackthorn AI, he focuses on expanding enterprise collaboration, bridging global opportunities, and driving AI adoption within regulated and high-impact industries.

Werner Baumgartner

Director DACH & MENA

Serhiy Protsenko, DrSci, Prof.

Principal Data Scientist

Serhiy Protsenko is an accomplished researcher and engineer with over a decade of experience in AI, data science, and machine learning. Holding a Doctor of Sciences degree, he has led research teams and guided large-scale data-driven projects across academia and industry.

At Blackthorn AI, Serhiy drives the development of production-ready ML systems, bringing together deep technical expertise with a clear business vision. His work spans from advanced model design and scalable infrastructure to aligning AI initiatives with client goals in highly regulated industries.

Serhiy Protsenko, DrSci, Prof.

Principal Data Scientist

Ivan Izonin, PhD, DrSci, Assoc. Prof.

Scientific Advisor, Artificial Intelligence

Ivan Izonin is an accomplished researcher and educator in Artificial Intelligence with a strong track record in applied machine learning, data-driven modeling, and intelligent systems. As Associate Professor at Lviv Polytechnic National University, he has authored over 300 scientific works, led international research collaborations, and supervised multiple PhD students in AI and data science. His expertise spans neural networks, big data analytics, and biomedical applications of AI. At Blackthorn AI, Ivan provides strategic scientific guidance, ensuring that cutting-edge AI methods are rigorously applied to high-impact industry challenges.

Ivan Izonin, PhD, DrSci, Assoc. Prof.

Scientific Advisor, Artificial Intelligence

What Clients Say About
Our Impact

Clients consistently praise our high accuracy in AI models, with projects achieving up to 84% precision and outperforming open-source models by 18%

Clutch Review

Thanks to their open management style, they had an exceptional partnership that resulted in success.

Serhii 
Ivanets

CTO, VAN Group
Clutch Review

They always delivered on time and showed 100% transparency in the project development.

Alejandro Gonzalez

Product manager, Monitoring Life
Clutch Review

Alex and his team work fast and provide quality work because they pay attention to detail.

Jason Mitakidis

Founder at HealthWorks Dx Inc.
Clutch Review

They were highly skilled in both development and scientific application needs in discovery.

Diana Kraskouskaya

CEO, Dalriada Drug Discovery
Clutch Review

Highly recommend!

All our needs were addressed in a very professional manner.

Yoanna
Gouchtchina

CEO, Quantum Skin
Our Awards & Certificates

#1 in Top 100 AI Companies
Clutch, 2024

Top Artificial Intelligence Company

Top Artificial Intelligence Company

Clutch, 2024
Cloud Engineer

Cloud Engineer

Google Cloud Certified Professional
Data Engineer

Data Engineer

Google Cloud Certified Professional
Cloud Architect

Cloud Architect

Google Cloud Certified Professional
Top Global AI Company

Top Global AI Company

Clutch, 2023
Solutions Architect

Solutions Architect

AWS Certified Associate
#1 in Top 100 AI Companies

#1 in Top 100 AI Companies

The Manifest, 2023
Data Engineer

Data Engineer

Google Cloud Certified Professional
Top Machine Learning AI Company

Top Machine Learning AI Company

Clutch, 2023
TensorFlow

TensorFlow

Developer Certificate
5.0 Overall Review Rating

5.0 Overall Review Rating

Clutch, 2022
 Oracle Certified

Oracle Certified

Java SE 8 Programmer Associate

Straight to Business?

Blackthorn AI empowers organisations to solve complex, cross-industry challenges with intelligent, scalable solutions

Book a Meeting
FAQ

Can’t find what you’re looking for? 
 Reach out below!

Contact Us
01

How can AI accelerate drug discovery for biotech startups?

+

AI can reduce early-stage drug discovery costs by up to 80% through predictive modeling, automated screening, and molecular simulation. At Blackthorn.ai, we develop custom AI pipelines that analyze complex biological data, identify promising compounds, and shorten the R&D cycle from years to months – helping biotech startups reach proof-of-concept faster and attract investor confidence.

02

How do you ensure data security and regulatory compliance?

+

Data protection in biotech is non-negotiable. We follow industry-grade standards like ISO 27001, HIPAA, and GDPR, implementing encrypted pipelines, controlled access layers, and secure on-premise or hybrid deployments. This ensures that sensitive genomic, clinical, and research data remains fully protected throughout development.

03

Can AI help us manage and analyze multi-omics data?

+

Absolutely. We build AI-powered multi-omics platforms that unify genomics, proteomics, and metabolomics datasets into one scalable environment. Our tools automate preprocessing, quality control, and cross-omics correlation – allowing scientists to focus on discovery instead of data wrangling.

04

We’re a small biotech startup – is AI development realistic for us?

+

Yes – and it’s often the smartest move you can make early on. We offer a 90-Day AI Discovery Sprint, where we build your first MVP (AI model or platform prototype) fast and cost-efficiently. This approach helps startups demonstrate technical feasibility to investors and gain early market traction without committing to a full-scale development yet.

05

How do you measure success in biotech AI projects?

+

We define clear KPIs from day one: prediction precision, experiment optimization rate, cost reduction, and time-to-result. Each milestone is benchmarked to measurable ROI, ensuring transparency and progress tracking throughout the project.